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T cell activation is mediated by microclusters (MCs)
containing T cell receptors (TCRs), kinases, and
adaptors. Although TCR MCs translocate to form
a central supramolecular activation cluster (cSMAC)
of the immunological synapse at the interface of
a T cell and an antigen-presenting cell, the role of
MC translocation in T cell signaling remains unclear.
Here, we found that the accumulation of MCs at
cSMAC was important for T cell costimulation.
Costimulatory receptor CD28 was initially recruited
coordinately with TCR to MCs, and its signals were
mediated through the assembly with the kinase
PKCq. The accumulation of MCs at the cSMAC was
accompanied by the segregation of CD28 from the
TCR, which resulted in the translocation of bothCD28
and PKCq to a spatially unique subregion of cSMAC.
Thus, costimulation is mediated by the generation of
a unique costimulatory compartment in the cSMAC
via the dynamic regulation of MC translocation.
INTRODUCTION
T cells require two distinct signals for activation and differentia-
tion: an antigen (Ag)-recognition signal transmitted through the
T cell receptor (TCR) upon recognition of the Ag peptide-major
histocompatibility complex (MHCp) on an antigen-presenting
cell (APC), and a costimulatory signal transmitted through costi-
mulatory receptors upon binding ligands expressed on APCs.
Costimulatory signals are essential for the full activation of
T cells for cytokine production, proliferation, survival, and func-
tional differentiation. In order to induce proper activation of
T cells through costimulation, expression of costimulatory re-
ceptors and their signals should be regulated in appropriate
strength and timing in a dynamic and quantitative fashion. Mod-ulation of costimulatory signals for T cell activation has been at-
tempted in the clinical setting, including the modulation of auto-
immune diseases, such as rheumatoid arthritis and psoriasis,
prevention of graft versus host disease in transplantation, effec-
tive vaccinations, and augmented antitumor immunity (Riley and
June, 2005; Salomon and Bluestone, 2001).
CD28, which is constitutively expressed on both naive and
effector T cells, plays a predominant role in costimulation by
binding its ligands, CD80 (B7-1) and CD86 (B7-2) (Acuto and
Michel, 2003; Chambers et al., 2001; Rudd and Schneider,
2003; Sharpe and Freeman, 2002). CD86 is constitutively
expressed at low amounts on most professional APCs and is
rapidly upregulated after activation, whereas CD80 is inducibly
expressed at a later time. Studies of genetically modified mice
lacking CD28 or CD80/CD86 have confirmed that CD28 signals
augment a variety of T cell functions, including cell-cycle
progression, antiapoptotic function, cytokine production, T
helper polarization, cytotoxic T cell differentiation, and humoral
immunity maturation. In addition to these direct functions,
CD28-mediated signals upregulate other costimulatory,
cytokine, and chemokine receptors, consequently inducing
secondary costimulatory responses. Although CD28 down-
stream signals have been extensively analyzed for more than
a decade, the precise mechanisms are not clearly understood.
Many molecules, such as phosphoinositide 3-kinase (PI3K)
(Harada et al., 2003; Pages et al., 1994), lymphocyte-specific
protein tyrosine kinase (Lck) (Holdorf et al., 1999; Liu et al.,
2000), growth factor receptor-bound protein 2 (Grb2) (Raab
et al., 1995), Grb2-related adaptor protein (Gads) (Watanabe
et al., 2006), IL2-inducible T cell kinase (Itk), the guanine-
nucleotide exchange factor Vav (Villalba et al., 2000), protein
kinase B (PKB) (also known as Akt) (Kane et al., 2001), protein
phosphatase 2A (PP2A) (Alegre et al., 2001; Chuang et al.,
2000), and protein kinase C q (PKCq) (Villalba et al., 2000),
have been implicated in CD28-mediated costimulatory signals.
However, because these molecules also function in TCR down-
stream signals, it is difficult to parse CD28-specific cascades
qualitatively and quantitatively.Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc. 589
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Costimulation Regulation by TCR-CD28 MicroclustersImmune responses are initiated by the communication
between Ag-specific T cells and APCs. An immunological syn-
apse (IS) is formed at the T cell-APC interface and is made up of
a central supramolecular activation cluster (cSMAC) containing
the TCR-CD3 complex and a peripheral SMAC (pSMAC)
containing the integrin LFA-1 (Grakoui et al., 1999; Monks et al.,
1998). An IS is dynamically generated at the interface between
a T cell and a B cell or a glass-supported planar bilayer, whereas
there was a report describing a multifocal pattern of TCR, not
cSMAC, between a T cell and a dendritic cell (DC) (Brossard
et al., 2005). We have recently reported that T cell activation is
spatiotemporally regulated by TCR microclusters (MCs) contain-
ing receptors, kinases, and adaptors (Bunnell et al., 2002; Campi
et al., 2005; Saito and Yokosuka, 2006; Yokosuka et al., 2005). As
the initial step of T cell activation, TCRs form small clusters at the
interface between a T cell and an APC or a planar bilayer.
Because these clusters contain both TCRs and phosphorylated
proteins, and intracellular calcium concentrations are increased
when a few MCs are generated, TCR MCs appear to function
as signalsomes for T cell activation. As a subsequent step, only
TCRs translocate to the center of the interface to result in cSMAC
formation. TCR MCs containing kinases and adaptors are
observed only at the peripheral edge of a T cell and not in cSMAC.
These findings mainly from the planar bilayer system imply that
TCR MCs are responsible for Ag recognition and the induction
of activation signals both at initial contact and at a later stage
for maintenance of activation, and that cSMACs are unable to
sustain signaling (Varma et al., 2006). This concept of MCs
serving as a key signalsome in T cell activation has raised impor-
tant questions on how CD28-mediated costimulation is spatially
and temporally regulated in the relationship with TCR MCs for
the full activation of T cells.
CD28 was previously reported to traffic into the T cell-APC
interface and to colocalize with PKCq upon Ag recognition
(Egen and Allison, 2002; Pentcheva-Hoang et al., 2004).
Regarding the localization of CD28 in the IS, CD28 was
reported to be localized at cSMAC (Bromley et al., 2001) or to
be segregated from TCR in IS (Andres et al., 2004a; Huang
et al., 2002; Tseng et al., 2005). Similar to TCR signals, CD28
signals were suggested to precede cSMAC formation because
CD28 upregulated TCR-induced intracellular calcium within
seconds after T cell-APC conjugation. It is also inferred that
CD28 localized in lipid rafts and augments the recruitment of
TCR downstream molecules to lipid rafts. However, the
dynamic regulation of CD28 and its related signaling molecules
is poorly understood.
We report here the results of molecular-imaging analysis of
CD28-mediated costimulation. CD28 was recruited coordinately
with TCR to MCs, and then PKCq was recruited to TCR-CD28
MCs by association with CD28, thereby resulting in the initial
activation of T cells. Furthermore, CD28 played a role in retaining
PKCq at a spatially unique and dynamic subregion of cSMAC,
leading to sustained signals for T cell activation.
RESULTS
Cluster Formation of CD28 at TCR MCs and cSMACs
To examine the dynamic movement of CD28 on a live T cell, we
visualized CD28 during T cell activation on a glass-supported590 Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc.planar bilayer by objective total internal reflection fluorescence
microscopy (TIRFM) (Tokunaga et al., 1997). We performed ret-
roviral infection to introduce EGFP-tagged CD28 (EGFP-CD28)
into CD4+ T cells from AND TCR-transgenic (AND-Tg) (specific
for moth cytochrome c 88-103 [MCC88-103] on I-Ek) CD28-
deficient (Cd28/) mice. The T cells were allowed to settle onto
a planar bilayer containing glycophosphatidylinositol (GPI)-
anchored I-Ek loaded with MCC88-103, ICAM-1-, and CD80-
GPI (I-Ek-ICAM-1-CD80) (Bromley et al., 2001; Grakoui et al.,
1999), and EGFP-CD28 movement in the entire process of
T cell-bilayer contact was imaged. The densities of I-Ek, ICAM-
1, and CD80 were adjusted to equal those of lipopolysaccharide
(LPS)-stimulated B cells, i.e., approximately 250, 100, and
60–120 molecules/mm2, respectively (Figure 1A).
CD80/CD86 binding has been shown to enhance both T cell
proliferation and IL-2 production as costimulatory functions.
Because we previously demonstrated that CD80-GPI enhances
IL-2 production by naive T cells on a planar bilayer (Bromley et al.,
2001), we applied silica beads coated with the same I-Ek-ICAM-
1-CD80-containing liposomes to stimulate T cells. AND-Tg naive
T cells showedmarked increases in IL-2 production, proliferation,
and CD69 expression upon bead stimulation (Figures 1B–1D).
Similar results were obtained with effector T cells (Figure S1,
available online).
Similar to the clustering of TCR-CD3 (Campi et al., 2005;
Yokosuka et al., 2005), CD28 was found to generate clusters
at the T cell-bilayer interface as soon as a T cell attached, and
the number of clusters increased during cell spreading. CD28
MC formation was completely dependent on the presence of
CD80 (Figure 2A and Movies S1 and S2). After cSMAC forma-
tion, CD28 MCs continued to be generated at the periphery of
the cell-bilayer interface and accumulated in the central region
(Figure 2B and Movies S3 and S4). Then, we examined whether
CD28 MCs move in a manner similar to TCR MCs, namely,
colocalization initially with TCR MCs and later with cSMACs.
Surprisingly, CD28 MCs colocalized with TCR MCs within the
first few minutes of contact (Figure 2C). The average number
of CD28 MCs is 136 ± 39.4 in ten representative cells at 2 min.
Almost all of the CD28 MCs (93.9% ± 7.4%) initially overlapped
with CD3. After cSMAC formation, a majority of CD28 translo-
cated to the center but, unexpectedly, segregated from TCR;
high-density regions of CD28 (CD28hi) and CD3 (CD3hi) segre-
gated from each other, although the CD28hi region exhibited
dim CD3 staining (CD3dim) and the CD3hi region exhibited dim
CD28 staining (CD28dim) (Figures 2C and 2D). Compared to
the cSMAC observed in the absence of CD28-CD80 interaction,
CD3hi regions were less massive because CD28hi regions inter-
fered with the formation of massive CD3hi regions. Collectively,
CD28hi regions appeared to be localized at relatively outer
regions of cSMACs. We also utilized a planar bilayer containing
Cy5-labeled ICAM-1-GPI as a marker for pSMAC to investigate
whether CD28hi regions localized in cSMAC or pSMAC. The
ICAM-1 ring merged with LFA-1 and surrounded both CD28hi
and CD28dim regions, indicating that these CD28 clusters are
localized in a previously unexplored outer region of cSMAC
(Figure 2E). Collectively, these data show that CD28 initially
accumulates and localizes at TCR MCs upon Ag stimulation,
and is later sorted to the outer region of cSMAC as a unique
compartment in IS.
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Costimulation Regulation by TCR-CD28 MicroclustersFigure 1. Costimulatory Function of CD80-GPI on Lipid Bilayers
(A) Five micron silica beads were coated with lipid bilayer containing I-Ek, ICAM-1, and CD80 at the same ratio as that for planar bilayers. Naive and LPS-
stimulated B cells, DCs, and silica beads were stained with anti-class II, ICAM-1, CD80, or CD86 and analyzed by FACS.
(B–D) Naive CD4+ T cells from AND-Tg mice were stimulated with silica beads that were coated with lipid bilayer containing I-Ek, ICAM-1, and CD80 at various
densities and were prepulsed with indicated doses of MCC88-103. (B) IL-2 production was measured by ELISA at 48 hr, (C) proliferation was measured by
3H-thymidine uptake at 60 hr, and (D) CD69 expression was measured by FACS at 6 hr after stimulation. Graphs (B and C) show mean ± standard deviation
(SD) (n = 3). A representative of three independent experiments is shown.Ligand-Dependent but Signal-Independent Formation
of CD28 Clusters
To examine whether particular downstream signals of CD28 are
required forMCformation,we reconstitutedvariousEGFP-tagged
wild-type (WT) ormutantCD28 intoAND-TgCd28/Tcells. Each
EGFP-CD28mutant contained a mutation in CD80/CD86 binding
site (Y123A), dimerization (C142S), or PI3K, Grb2, andGads bind-
ing site (Y189F), or a deletion of cytoplasmic 16 amino acids crit-
ical for lipid-raft association (D16) or the entire cytoplasmic tail
(DCP) (Andres et al., 2004b; Holdorf et al., 1999; Pages et al.,
1994; Schneider et al., 1995). The surface expression of all
CD28 mutants was nearly equal on activated T cells (data not
shown). We found no substantial differences in CD28 MC forma-
tion and distribution both at initial contact and after cSMAC
formation among all CD28 mutants except Y123A. Y123A failed
to form CD28 MCs, whereas even the CD28DCP mutant formed
MCs (Figure 3), indicating that CD28 MC formation depends on
CD28-CD80 binding but not on downstream signals of CD28.
Nonetheless, the CD28 cytoplasmic domain may still recruit or
associate with specific signaling molecules for costimulation.
CD28 Cluster and Its Downstream Signals
We analyzed a set of candidate molecules that move and colo-
calize with CD28 on a planar bilayer. TCR-proximal signals
were first analyzed by staining for phosphorylated CD3z
(Figure S2) or the kinase Zap70 (data not shown), but their phos-
phorylation status was not altered by the presence of CD80-GPI
(Herndon et al., 2001). Then, we analyzed PI3K as a likely candi-
date for mediating costimulation because PI3K was clearly dem-
onstrated to bind to the ‘‘YMNM’’ motif of CD28 cytoplasmic tail
and to augment IL-2 production (Harada et al., 2003; Truitt et al.,
1994). When AND-Tg T cells expressing EGFP-p55a as anindicator of type I PI3K were plated on an I-Ek-ICAM-1-CD80
planar bilayer, p55a clusters were transiently observed at the
entire cell-bilayer interface. However, they disappeared soon
after moving toward the center and did not accumulate at
cSMAC, similar to Zap70 and the adaptor SLP-76 (Yokosuka
et al., 2005) (Figure S3A and data not shown). The presence
of CD80-GPI on the planar bilayer resulted in a slight but signif-
icant enhancement of area (0.050 ± 0.026 mm2 with CD80-GPI;
0.037 ± 0.024 mm2 without CD80-GPI, p value < 0.001 with Stu-
dent’s t test) and fluorescence intensity of EGFP-p55a clusters
(0.282% ± 0.160% with CD80-GPI; 0.182% ± 0.109% without
CD80-GPI, p < 0.001 with Student’s t test) (Figure S4), confirm-
ing that PI3K is recruited to and enriched at TCR-CD28 MCs
through CD28-CD80 binding during initial activation. However,
these movements of PI3K clusters did not simply correlate with
the accumulation of CD28 at cSMAC. Two-color analysis of
AND-TCR T cell hybridomas expressing both ECFP-CD28 and
EYFP-p85a confirmed this result—the initial colocalization of
PI3K with TCR-CD28 MCs and the dissociation from CD28 in
cSMAC later (Figure S3B). Catalytic subunit p110d showed sim-
ilar movement to p55a and p85a (data not shown). Furthermore,
we analyzed cluster formation of Grb2, Gads, Vav1, and Itk in
AND-Tg T cells expressing each EGFP fusion protein because
these molecules have been suggested to functionally correlate
with CD28 costimulation. However, we observed no accumula-
tion at cSMACs regardless of the presence of CD80-GPI (data
not shown).
CD28-Mediated Translocation of PKCq to T Cell-APC
Interface
We then analyzed PKCq movement by using the assay
described above, because PKCq is activated after stimulationImmunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc. 591
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Costimulation Regulation by TCR-CD28 Microclustersthrough both TCR and CD28 (Berg-Brown et al., 2004; Pfeifhofer
et al., 2003; Sun et al., 2000), is segregated in IS with CD28
costimulation, is recruited to lipid raft, and plays a critical
role in NF-kB activation. AND-Tg T cells expressing ECFP-
CD28 and EYFP-PKCq were conjugated with a dendritic cell
line, DC-1, expressing I-Ek, ICAM-1, and transfected CD80,
and the localization of CD28 and PKCq was imaged. As
previously reported (Huang et al., 2002), almost all T cells
(96.6%, n = 56) showed clear accumulation and colocalization
of CD28 with PKCq as patched clusters on MCC88-103-
pulsed CD80+ DC-1 (Figures 4A–4C). Importantly, a majority
of T cells (81.7%, n = 83) exhibiting conjugate formation
with CD80 DC-1 showed PKCq patch 2 min after conjuga-
tion, whereas only a minor population (1.6%, n = 62) showed
the patch 20 min later (Figure 4C). These data suggest that Ag
Figure 2. Ligand-Dependent Clustering of
CD28 at TCR-CD3 MCs and at cSMAC
(A and B) AND-Tg T cells expressing EGFP-CD28
were plated on a planar bilayer containing (top)
I-Ek and ICAM-1 plus (bottom) CD80 (prepulsed
with MCC88-103). Cells were imaged at video
rate (30 frames/s) with TIRFM (time shown above
images). Images from 10 to 300 s are depicted in
(A) and at 10 min after initial contact in (B). The
interval between images is 10 s. Scale bars repre-
sent 5 mm. A representative of five independent
experiments is shown. Real-time images in (A) and
(B) are available in Movies S1–S4.
(C and D) Cells in (A) and (B) were fixed at 2 or
20 min after cell-bilayer contact, stained for CD3,
and imaged by confocal microscopy. Histograms
on right panels show fold fluorescence intensities
of EGFP-CD28 (green) and CD3 (red) on the
diagonal yellow lines in DIC images.
(D) Fluorescence intensities of CD3 and EGFP-
CD28 in CD28 (c-28) or CD3 (c-3) clusters in
cSMAC or pSMAC (p) were compared to the inten-
sities of the entire interface in the cell in (C)
bottom two rows (n = 10). *, p value < 0.001 with
Student’s t test. Scale bars represent 5 mm. A rep-
resentative of three independent experiments is
shown.
(E) AND-Tg T cells expressing EGFP-CD11a (top)
or EGFP-CD28 (bottom) were stained with Alexa
Fluor 546-labeled anti-TCRb Fab and were plated
on a planar bilayer containing I-Ek, CD80, and
Cy5-labeled ICAM-1 (prepulsed with MCC88-
103). Cells were imaged real time by confocal
microscopy 20 min after contact. Histograms on
the right panels are described as in (C). Scale bars
represent 5 mm. A representative of two indepen-
dent experiments is shown.
stimulation in the absence of CD80 in-
duces transient translocation of PKCq to
the plasma membrane (Figure 4A, row 3;
Figure 4B, top; and Figure 4C, left) and
that the CD28-CD80 interaction is re-
quired for the coclustering of CD28 and
PKCq and for the stable and sustained
translocation of PKCq to the T cell-APC
interface (Figure 4A, bottom; Figure 4B,bottom; and Figure 4C,
right).
We further analyzed the kinetics and distribution of PKCq by
using a planar bilayer and AND-Tg T cells expressing EGFP-
PKCq. PKCq clusters were transiently observed even in the ab-
sence of CD80-GPI (Figure 4D, top and Movie S5). In contrast,
PKCq accumulated to form clear clusters and persisted on the
bilayer with CD80-GPI at initial activation (Figure 4D, bottom
andMovie S6). Furthermore, after cSMAC formation, PKCq clus-
ters accumulated at the central region of the cell-bilayer interface
in an annular form, which lasted for at least 60min (Figure 4E and
Movies S7 and S8). These data demonstrated that CD28-CD80
interaction enhanced the accumulation of PKCq both at MCs
initially and at the central region of cell-bilayer interface after
cSMAC formation.592 Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc.
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Costimulation Regulation by TCR-CD28 MicroclustersFigure 3. CD28 Cluster Formation Is Independent of CD28 Cytoplasmic Tail
AND-Tg T cells fromCd28/mice were reconstituted with EGFP-WT (top two rows) or mutant CD28 (bottom five rows, Y123A, C142S, Y189F,D16, andDCP) by
retroviral infection. Cells were plated on a planar bilayer containing I-Ek and ICAM-1 (top row) plus CD80 (bottom six rows) (prepulsed with MCC88-103), fixed 2
min (left columns) or 20 min (right columns) after contact, and stained for CD3. The localizations of CD28 (green) and CD3 (red) were imaged by confocal micros-
copy, and the fold fluorescence intensities on diagonal yellow lines are shown by histograms. Scale bars represent 5 mm. A representative of three independent
experiments is shown.CD28-Mediated Localization of PKCq at TCR MCs
and cSMACs
Next, we examined whether PKCq clusters colocalized with TCR
or CD28 during initial and sustained activation. Costaining of
PKCq clusters with CD3 revealed that almost all PKCq clusters
(95.2%, n = 1302 in ten cells) mergedwith TCRMCs at initial con-
tact (Figure 5A, top). After cSMAC formation, a majority of T cells
(76.5%, n = 132) showed PKCq accumulation in the CD3dim re-
gion in an annular form and exclusion from the CD3hi region in
cSMACs (Figure 5A, bottom and Figure 5B). Because this
PKCq accumulation resembles that of CD28 clusters, we exam-
ined the colocalization of CD28 with PKCq by using AND-Tg
Cd28/ T cells expressing both EYFP-PKCq and ECFP-CD28
on a planar bilayer. Depending on CD28-CD80 interaction,
almost all cells (93.4%, n = 61) initially exhibited colocalization
of PKCq with TCR-CD28 MCs (Figures 5C and 5D, and
Figure S5A). Thereafter, PKCq translocated to and accumulated
at the center of the interface. After cSMAC formation, PKCq per-sistently localized with CD28 at the outer region of cSMAC by
segregating from core CD3 (Figures 5E and 5F, and Figure S5B).
A majority of the cells with the annular form of CD28 clusters
(81.8%, n = 33) colocalized with both PKCq clusters and the
CD3dim region. As shown in Figure 2E, the annular form of
PKCq-CD28 clusters settled in cSMACs (Figure 5G). PKCq and
CD28 clusters in the annular form were also imaged at the inter-
face betweenEGFP-PKCq-expressingAND-Tg Tcells andDC-1,
although the frequencywas lower and the imageswere less clear
compared to those in the planar bilayer, probably as a result
of membrane ruffling and variety expression of costimulatory
receptor ligands on APCs (Figure S6 and Movie S9).
To understand the mechanism of CD28-mediated PKCq
recruitment, we examined the physical association between
CD28 and PKCq. Indeed, we found that PKCq was coprecipi-
tated with CD28 in lysates from T cell hybridomas expressing
both ECFP-CD28 and EYFP-PKCq (the same cells as those for
imaging in Figures 4A and 4B) upon PMA stimulation (Figure 5H,Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc. 593
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Costimulation Regulation by TCR-CD28 Microclustersleft four columns in PMA [] and [+]). More importantly, this phys-
ical association was identified in both effector and naive T cells
from mice upon PMA stimulation (Figure 5I and data not shown).
The CD28-PKCq assembly appears to be weak because the as-
sociation was detectable only with mild detergent, such as dig-
itonin (Figure S7). These results suggest that CD28 recruits
PKCq by forming the assembly, although there is no evidence
of the direct interaction of CD28 with PKCq.
5C.C7-Tg T cells, whose Ag specificity is the same as that of
AND-Tg T cells, generate smaller cSMACs because they have
lower TCR affinity than AND-Tg T cells upon stimulation with
the same concentrations of Ag on a planar bilayer. Under the
condition in which cSMACs were not well formed by 5C.C7-Tg
T cells with lower concentrations of MCC88-103 (1 and 0.1 mM),
PKCq still accumulated in an annular form (Figure S8). This
result suggests that the annular accumulation of PKCq clusters
Figure 4. CD28-CD80 Binding Maintains
PKCq Translocation to Cell-Cell and Cell-
Bilayer Interface
(A and B) AND-TCR T cell hybridomas expressing
ECFP-CD28 and EYFP-PKCq were conjugated
with MCC88-103-pulsed or unpulsed DC-1,
expressing or not expressing CD80, and imaged
by confocal microcopy 2 min or 20 min after con-
jugation. Magnified images of the areas enclosed
by white squares in (A) are depicted in (B). Scale
bars represent 5 mm. A representative of three
independent experiments is shown.
(C) Conjugated pairs in (A) were categorized by
translocation of ECFP-CD28 and/or EYFP-PKCq
at the interface (2 min, n = 32, 108, 83, and 56;
20 min, n = 70, 63, 62, and 44, from left to right).
A representative of three independent experi-
ments is shown.
(D and E) AND-Tg T cells expressing EGFP-PKCq
were plated on a planar bilayer containing I-Ek and
ICAM-1 (top) plus CD80 (bottom) (prepulsed with
MCC88-103). Cells were imaged at video rate (30
frames/s) with TIRFM (time shown above images).
Images from 10 to 300 s are depicted in (D) and at
10 min after initial contact, in (E), and the interval
between images is 10 s. Scale bars represent
5 mm. A representative of five independent exper-
iments is shown. Real-time images in (D) and (E)
are available in Movies S5–S8.
takes place without strong TCR-MHCp
binding, which leads to clear cSMAC for-
mation, but is dependent on CD28-CD80
binding.
Dynamic Maintenance of CD28-
PKCq Clusters at cSMAC
The critical role of CD28 in retaining PKCq
at cSMAC was confirmed by interrupting
CD28-CD80 binding, via Ig fusion pro-
teins of WT cytotoxic T lymphocyte anti-
gen-4 (WT CTLA-4 Ig). The formation of
both CD28 and PKCq clusters in an annu-
lar formwas diminished by the addition of
WT CTLA-4 Ig but not Y139A (YA) CTLA-4, a binding mutant for
CD80/CD86. The percentage of cells forming annular CD28 and
PKCq clusters was reduced from 87.2% to 32.4% and from
42.3% to zero, respectively (Figures 6A and 6B). Severe reduc-
tion of IL-2 production was observed when CD28-CD80 binding
was blocked by WT CTLA-4 Ig at 2 min after stimulation, when
only TCR-CD28-PKCq-containing MCs were generated, as
well as at 10 min after stimulation, when CD28-PKCq annular
clusters were set up (Figure 6C). Because most PKCqmolecules
accumulated at CD28 clusters after cSMAC formation, these re-
sults suggest that both initial MCs and the annular form of PKCq
clusters are correlated with T cell function.
To further analyze CD28 function in the recruitment of PKCq to
the plasma membrane, we examined the relocalization of PKCq
at CD28 clusters. In our systems, CD28 MCs were generated,
and theseMCs accumulated at the central region of the interface594 Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc.
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Costimulation Regulation by TCR-CD28 Microclustersbetween T cells and I-Ek-ICAM-1-CD80 planar bilayers without
MCC88-103. PKCq was mainly localized in cytosol without Ag
stimulation; however, it efficiently translocated to CD28 clusters
upon PMA stimulation (Figures 6D and 6E). These results sug-
gest that CD28 clusters recruit and retain PKCq and induce the
formation of the annular form of PKCq clusters.
TCR clusters in cSMAC were found to be relatively stable on
the basis of a fluorescence recovery after photobleaching
(FRAP) study (Grakoui et al., 1999).We investigated thedynamics
of annular forms of CD28 and PKCq clusters in cSMAC by FRAP
(Figures 6F and 6G andMovies S10 andS11). Indeed, both CD28
and PKCq showed rapid recovery of their clusters, indicating ac-
tive maintenance of the structure and dynamic exchange within
cSMAC. PKCq exhibited more rapid and complete recovery
than CD28, probably as a result of its higher mobility as a cyto-
plasmic protein. These data suggest that the cytoplasmic tail of
CD28 functions to dynamically recruit and concentrate PKCq
by specific association, and they indicate that the annular form
of PKCq clusters is dynamically generated and maintained by
recruiting CD28-PKCq from peripheral TCR-CD28 MCs.
Furthermore, PKCq clusters in the annular form were stained
with anti-phospho-PKCq at the outer region of cSMAC in a
CD28-CD80-dependent manner in normal T cells, although a
question on the antibody specificity has been raised (Lee et al.,
2005) (Figure S9). The result suggests that PKCq that accumu-
lated in the annular form was active in the induction of costimu-
latory signals.
Regulation of PKCq Translocation to TCR-CD28 MCs
by CD28 Signals
To examine the requirement of the cytoplasmic tail of CD28 for
PKCq translocation to TCR-CD28 MCs, we established a series
of AND-TCR T cell hybridomas expressing EYFP-PKCq and var-
ious ECFP-CD28mutants. First, we analyzed the translocation of
PKCq to the T cell-APC interface by using DC-1 with or without
CD80 expression (Figures 7A and 7B).WTCD28 exhibited coloc-
alization with PKCq at the T cell-APC interface upon Ag stimula-
tion 2 min and 30 min after conjugation. As in Figure 4A, 2 min
after T cell-APC conjugation, the translocation of PKCq to the in-
terface in T cells expressing CD28 with the mutated or deleted
cytoplasmic tail (Y189F, D16, and DCP) was similar to that in
T cells expressing WT CD28. In contrast, PKCq patches that co-
localized with CD28 showed a decrease in number in T cells ex-
pressing CD28 with the mutated or deleted cytoplasmic tail
(Y189F, D16, and DCP) 30 min after conjugation (Figure 7B).
The colocalization of CD28 with PKCq was further analyzed on
the planar bilayer with AND-Tg Cd28/ T cells (Figure 7C) and
AND-TCR T cell hybridomas (Figure 7D and Figure S10).
Whereas CD28 MCs were generated independently of the cyto-
plasmic tail of CD28, PKCq was not clearly recruited and did not
form MCs if the cytoplasmic tail was mutated or deleted
(Figure 7C and Figure S10). These data demonstrate that CD28
MC formation is independent of, but lasting recruitment of
PKCq to CD28 MCs is completely dependent on, the
cytoplasmic tail of CD28. Quantification of the number of AND-
TCR T cell hybridomas exhibiting colocalization of PKCq clusters
with WT or mutant CD28 clusters is shown in Figure 7D. Consis-
tent with these imaging data, biochemical analysis revealed that
the physical association between PKCq- and CD28-bearingcytoplasmic tail mutations was much weaker than that between
PKCq and WT CD28 (Figure 5H). To clarify the function of the
colocalization of CD28 with PKCq within the same TCR MCs,
we reconstituted AND-Tg T cells from Cd28/ mice with these
CD28 mutants and stimulated with anti-CD28 plus PMA to
analyze costimulatory function (Figure 7E). We noted a strong
correlation among CD28-PKCq colocalization, physical associa-
tion, and CD28-mediated costimulation, suggesting that CD28-
mediated costimulation for the full activation of T cells is
mediated by the recruitment of PKCq to TCR-CD28 MCs.
DISCUSSION
In this study, we illustrated the dynamic aspects of CD28-
mediated costimulation in relation to TCR MCs. CD28 colocal-
izes with TCR to form TCR-CD28 MCs together with signaling
molecules as signalsomes, where CD28 plays a critical role in
recruiting PKCq to MCs at initial activation, and then to the outer
region of cSMAC, possibly for sustained activation to exhibit
effector functions. Previous studies have indicated that TCR
MCs generated at the periphery of IS induce activation signals,
whereas cSMAC may not be responsible for transducing activa-
tion signals, because phosphorylated proteins are detected
almost in peripheral MCs and not in cSMAC (Yokosuka et al.,
2005), and that Ca2+ signaling is not sustained in the absence
of peripheral MCs (Varma et al., 2006). However, the present
result of CD28-PKCq signaling at the outer region of cSMAC
leads to the idea that cSMAC also provides signal competency
for costimulation and that different signal clusters are responsi-
ble for TCR-mediated and costimulatory signals for the mainte-
nance of T cell activation.
The translocation of CD28 to the T cell-APC interface before
cSMAC formation was previously reported (Andres et al.,
2004a), but we demonstrated that CD28 colocalizes with TCR
and its downstream molecules as a TCR-CD28 MC. This colo-
calization of TCR with CD28 in the same MC coincides with
the findings that CD28 shares most of the downstream mole-
cules with TCR. We searched for a molecule that contributes
specifically to CD28 signals by colocalizing initially with TCR
MCs and then translocating to CD28 clusters at the outer region
of cSMAC. Although CD28 signal enhanced the colocalization of
PI3K with CD28, PI3K clusters differ from that of CD28. Finally,
we found that PKCq met the criteria for the specific mediator
of CD28 signals: accumulation at TCR-CD28 MCs initially and
at cSMAC later.
PKCq is known as a downstream molecule of CD28. PKCq-
and CD28-deficient animals revealed similar functional defects
(Pfeifhofer et al., 2003; Sun et al., 2000), although the physical
interaction has not been shown. We provided evidence of the
functional assembly between CD28 and PKCq in three aspects:
(1) PKCq is contained within early activation signalsomes as
TCR-CD28 MCs and translocates to cSMAC with CD28; (2) the
physical association of CD28 with activated PKCq is demon-
strated by coimmunoprecipitation; and (3) the early localization
of PKCq at MCs and the late at cSMAC are functionally
associated with IL-2 production. The similar regulation was
observed in B cells; CD19 enhanced B cell functions through
its colocalization with B cell receptors (BCRs) and Syk as BCR
MCs (Depoil et al., 2008).Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc. 595
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Costimulation Regulation by TCR-CD28 MicroclustersPKCq has been considered as a marker for cSMAC during
T cell activation (Monks et al., 1998), whereas CD28 was sug-
gested to play a role in segregation of PKCq in IS (Huang et al.,
2002; Tseng et al., 2005). In addition to the finding of colocaliza-
tion of CD28-PKCq in TCRMCs, we identified a unique functional
subregion of cSMAC where CD28 and PKCq accumulated. The
generation of this subregion appears to depend on both localiza-
tion and density of CD28 because PKCq was colocalized in
CD28hi but not TCR-CD3hi region. Furthermore, CD28 cluster
formation depends on the density of CD28 and CD80/CD86 on
T cells and APCs, and on the avidity of TCR, through the compe-
tition between CD28-CD80/CD86 and TCR-MHCp (unpublished
data).We propose a functional region of cSMAC, CD3dim CD28hi,
as ‘‘costimulatory signalsome’’ for T cell activation. We demon-
strated by FRAP analysis that no signal molecule translocated to
the CD3hi region, and the CD3dim region was more flexible and
dynamically regulated than the CD3hi region (unpublished
data). The CD3hi region within cSMACmay be a negative regula-
tory compartment for T cell activation as suggested (Varma et al.,
2006). The CD3dim/CD3hi ratio appears to vary depending on the
strength of TCR stimulation. A strong stimulus may induce more
CD3hi region for endocytosis or degradation of TCR complexes,
whereas a weak stimulus may result in more CD3dim regions that
are susceptible to CD28-PKCq-mediated costimulation. This is
consistent with previous data suggesting negative regulatory
functions of cSMAC by signal-strength-dependent TCR degra-
dation (Cemerski et al., 2007). Our results suggest that cSMAC
may inherit yin and yang functions for the regulation of T cell
activation: endocytosis or degradation of the TCR complex for
negative regulation through the CD3hi region, but CD28-PKCq
accumulation for sustained T cell signaling through the spatially
distinct region.
Our data depicted both spatial and temporal differences in the
dynamics of PKCq and Zap70-SLP-76 for MC formation. PKCq
may be recruited to the plasma membrane via diacylglycerol
(DAG) or in a phospholipase C-g1 (PLCg1)-DAG-independent
manner (Villalba et al., 2002) and may be functionally activated
by membrane translocation (Bi et al., 2001), whereas Zap70
and SLP-76 require phosphorylation for retention on the cell sur-
face by associating with CD3 and LAT, respectively. Thus, PKCqmay associate with TCR-CD28 MCs via two steps—initial
recruitment to the cell surface by DAG binding, followed by lat-
eral movement to TCR-CD28 MCs through the association with
CD28. The frequency of cells with PKCq translocation in CD28
Y189F, PI3K-binding mutant was lower than that in D16 mutant,
in both T cell-APC and T cell-bilayer experiments, whereas
stimulation of Y189F CD28-expressing cells with PMA plus
anti-CD28 augmented the proliferation, suggesting the involve-
ment of PI3K in PKCq membrane translocation and the partial
rescue of T cell response by PMA-mediated PKCq relocation.
CD28-mediated membrane translocation and the colocaliza-
tion of CD28 with PKCq could be explained by several mecha-
nisms including recruitment into lipid raft and DAG-gradient.
However, we failed to obtain the evidence to support these ideas
(see Supplemental Data). Moreover, cell adhesion by CD28 may
contribute to the functional recruitment of PKCq to CD28 clusters
through cytoskeletal rearrangement (Kaga et al., 1998). In this
context, because filamin-A was reported to translocate into IS,
associate with actin and PKCq, and enhance IL-2 production in
a CD28-CD80-dependent manner (Hayashi and Altman, 2006;
Tavano et al., 2006), this mechanism might be involved in the
colocalization of CD28 with PKCq.
During T cell activation, the functional enhancement of T cell
responses by CD28-mediated costimulation is prominent for
T cell activation with weak TCR stimulus. Imaging studies have
suggested that CD28 supports IL-2 production if no cSMAC is
generated (Purtic et al., 2005) or if APC has a low concentration
of Ag or self-Ag (Wulfing et al., 2002). In relation to these studies,
we observed that CD28-PKCq clusters could be generated even
if cSMAC were not clearly generated with lower-affinity TCR,
suggesting further differential regulation of two spatially distinct
signaling clusters: Peripheral MCs and annular clusters in
cSMAC may lead to different signaling pathways, such as
Ca2+-NFAT and NF-kB activation. The spatiotemporal regulation
of TCR-CD28MC formation in cSMACmay explain the complex-
ity of intercommunicating molecules downstream of TCR and
CD28.
Whereas CD28 localization in IS had been extensively investi-
gated, nano-scale imaging of costimulatory receptor CD28 and
its signal-transduction partners PI3K and PKCq by TIRFM hasFigure 5. PKCq Colocalizes with CD28 at TCR-CD3 MCs at Initiation and Forms Annular Clusters with CD28 after cSMAC Formation
(A and B) AND-Tg T cells expressing EGFP-PKCq were plated on a planar bilayer containing I-Ek, ICAM-1, and CD80 (prepulsed with MCC88-103), fixed at the
indicated times, and stained for CD3. Histograms show fold fluorescence intensities of PKCq (green) and CD3 (red) on the diagonal yellow lines in DIC images.
PKCq clusters at 20 min (A, bottom) were categorized into random or annular clusters ([B], CD80, n = 85; CD80+, n = 132). Scale bars represent 5 mm. A
representative of two independent experiments is shown.
(C–F) AND-Tg T cells from Cd28/ mice were transfected with EYFP-PKCq (rows 1 and 3) plus ECFP-CD28 (rows 2 and 4) and plated on a planar bilayer con-
taining Cy5-labeled I-Ek and ICAM-1 (top two rows) plus CD80 (bottom two rows). Cells were imaged by confocal microscopy 2min (C) or 30min after contact (E).
Percentage of cells containing I-Ek clusters colocalizing with PKCq clusters in (C) was calculated ([D], n = 30, 16, 34, and 61, from left to right). Colocalization
of CD28, PKCq, and I-Ek at cSMAC was analyzed (E), and fluorescence intensities of Cy5-I-Ek (left), ECFP-CD28 (middle), and EYFP-PKCq (right) in CD28
(c-28) or CD3 (c-3) clusters in cSMAC or pSMAC (p) in (E) bottom row were compared to the intensities of entire cell-bilayer interfaces ([F], n = 10).
*, p value < 0.001 with Student’s t test. Scale bars represent 5 mm. A representative of three independent experiments is shown. Fold fluorescence intensities
of ECFP-CD28, PKCq, and I-Ek on the diagonal yellow lines in DIC images were depicted in histograms in Figure S5.
(G) AND-Tg T cells expressing EGFP-PKCq were stained with Alexa Fluor 546-anti-TCRb Fab and plated on a planar bilayer containing I-Ek, CD80, and Cy5-
labeled ICAM-1. Cells were imaged by confocal microscopy 2 min (top) or 30 min after contact (bottom). Histograms are described as in (A). Scale bars represent
5 mm. A representative of two independent experiments is shown.
(H and I) Physical interaction between CD28 and PKCq upon activation in T cell hybridomas (H) and normal splenic T cells (I). AND-TCR T cell hybridomas
expressing EYFP-PKCq and ECFP-WT or cytoplasmicmutant CD28 in Figure 3 were unstimulated (left) or stimulated for 2min with 50 nMPMA (right). Cell lysates
were immunoprecipitated with anti-CD28 (rows 1 and 4) or control (row 2) and blotted for EYFP-PKCq (top three rows) and ECFP-CD28 (bottom two rows) (H).
Splenic T cells were unstimulated (left) or stimulated (right) as in (H). Cell lysates were immunoprecipitated with anti-CD28 (rows 1 and 4) or control (row 2) and
blotted with anti-PKCq (top three rows) or anti-CD28 (bottom). WCL denotes whole-cell lysate. A representative of three independent experiments is shown.Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc. 597
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Costimulation Regulation by TCR-CD28 MicroclustersFigure 6. Dynamic Regulation of CD28-
PKCqClusters in an Annular Format cSMAC
and Their Function in IL-2 Production
(A and B) 5C.C7-Tg T cells expressing EGFP-
CD28 (A) or EGFP-PKCq (B) were plated on a
planar bilayer containing I-Ek, ICAM-1, and CD80
(prepulsed with MCC88-103) for 20 min and
further incubated with WT or YA CTLA-4 Ig for
10 min. Cells were imaged by confocal micros-
copy and categorized into random or annular
clusters (CD28 YA, n = 141;WT, n = 114; PKCq YA,
n = 52; WT, n = 44). Scale bars represent 5 mm. A
representative of three independent experiments
is shown.
(C) Reduction of IL-2 production by blocking
CD28-CD80 interaction. 5C.C7-Tg effector T cells
were stimulated by splenic B cells pulsed or un-
pulsed with MCC88-103, and WT (black) or YA
CTLA-4 Ig (gray) was added at the indicated times.
After 2 days, IL-2 was measured by ELISA. The
graph shows mean ± SD (n = 3) obtained by two
independent experiments.
(D and E) Relocalization of PKCq to CD28 clusters.
AND-TCR T cell hybridomas expressing both
ECFP-CD28 and EYFP-PKCq were plated on a
planar bilayer containing I-Ek, ICAM-1, and CD80
without MCC88-103 and were allowed to develop
CD28 clusters for 15 min. Translocation of EYFP-
PKCq in the same cells was imaged before and
after 5 mMPMA stimulation (D). The average inten-
sities of ECFP-CD28 (left) and EYFP-PKCq (right)
in cSMAC in the cells in (D) were compared to
those of the entire interfaces ([E], n = 11). Scale
bars represent 5 mm. A representative of two
independent experiments is shown.
(F and G) Dynamism of CD28 and PKCq clusters in
an annular form. AND-Tg T cells expressing EGFP-
CD28 (F) or EGFP-PKCq (G) were plated on a pla-
nar bilayer as in (A) for 20 min. Recoveries of CD28
and PKCq were analyzed by FRAP at specific
regions (white square) of the annular clusters.
Images were obtained every 2.5 s by confocal mi-
croscopy, and fluorescence recovery ratios were
calculated ([F], n = 28; [G], n = 30). Green lines in
graphs depict the recovery ratios of cells in top panels. Mathematical formulas are approximated curves involving 28 or 30 cells. Scale bars represent 5 mm.
A representative of two independent experiments is shown. Real-time images in (F) (G) are available in Movies S9 and S10.provided a new vision of the two costimulatory mechanisms that
are functionally critical: the early recruitment of PKCq and PI3K
to TCR-CD28 MCs and the late formation of a dynamic subre-
gion in cSMAC enriched with PKCq but depleted of TCR and
PI3K.
EXPERIMENTAL PROCEDURES
Reagents
Antibodies and reagents were purchased from the following suppliers: anti-
mCD28, biotinylated anti-mCD33, FITC-anti-mCD11c, phycoerythrin (PE)-
anti-mMHC class II, PE-mICMA-1, PE-anti-mCD69, PE-anti-mCD80,
PE-anti-mCD86, and PE-isotype matched control Ig were from eBioscience;
anti-PKCq and anti-phospho PKCq, from Santa Cruz; Alexa Fluor 647-anti-
CD3 and Alexa Fluor 647-anti-phospho CD3z, from BD PharMingen; Alexa
Fluor 488-streptoavidin, Alexa Fluor 647-anti-rabbit IgG, and Alexa Fluor
548-anti-hamster IgG, from Molecular Probes; and goat polyclonal anti-
CD28 and rabbit polyclonal anti-PKCq, from Santa Cruz. HRP-anti-GFP was
from Miltenyi Biotec and phorbol 12-myristate 13-acetate (PMA) was from598 Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc.Sigma. Anti-mouse CD28 was provided by R. Abe (Science University of
Tokyo, Japan).
Mice and Cells
AND-Tg and 5C.C7-Tg mice on Rag2/ background were provided by R.N.
Germain (National Institutes of Health, NIH) and K. Yasutomo (Tokushima
University, Japan), respectively, and Cd28/ mice were purchased from
Jackson Laboratories. The DC line, DC-1, was provided by J. Kaye. T cell
hybridoma expressing AND-TCR was established by cell fusion of activated
AND-Tg CD4+ T cells with TCR-negative BW5147, as previously shown
(Kruisbeek, 1997).
Primary Cell Culture and Transduction
Expression constructs were transiently transduced into Phoenix packaging
cells (provided by G. Norlan, Stanford University), via LipofectAmine Plus (In-
vitrogen). Retroviral supernatants were concentrated tenfold by centrifugation
at 80003 g for 12 hr. CD4+ T cells were purified fromAND-TgRag2/ or AND-
Tg Cd28/ Rag2/ mice and stimulated with 5 mM MCC88-103 (ANERA-
DLIAYLKQATK) and irradiated spleen cells from B10.BR mice. One day after
stimulation, the cells were suspended in the retroviral supernatant and
Immunity
Costimulation Regulation by TCR-CD28 MicroclustersFigure 7. Function of CD28 Cytoplasmic Tail in the Translocation of PKCq to T Cell-APC Interface and TCR-CD28 MCs
(A and B) AND-TCR T cell hybridomas expressing EYFP-PKCq (yellow) and ECFP-WT or mutant CD28 (cyan) were conjugated with MCC88-103-pulsed DC-1
without ([A], top row) or with CD80 ([A], bottom seven rows). Cells were imaged real time at the indicated times by confocal microscopy. *, DC-1. Scale bars
represent 5 mm. In fixed samples, conjugating pairs with PKCq translocated to cell-cell interface were counted ([B], n = 60, 68, 60, 115, 68, 65, 73, and 122
from left to right). A representative of two independent experiments is shown.
(C) AND-Tg T cells from Cd28/mice were reconstituted with ECFP-WT or mutant CD28 (cyan) and EYFP-PKCq (yellow), plated on a planar bilayer containing
Cy5-I-Ek (red) and ICAM-1 plus CD80 (prepulsed with MCC88-103), and imaged by confocal microcopy in real time 2 min or 30 min after cell-bilayer contact.
Scale bars represent 5 mm. A representative of four independent experiments is shown.
(D) AND-TCRT cell hybridomas in (A) were plated on a planar bilayer as in (C). Imageswere obtained in real time by confocalmicroscopy immediately after contact
(Figure S10), and the percentages of cells containing PKCq clusters are counted (n = 38, 26, 70, 42, 70, 83, 59, and 44 from left to right). A representative of two
independent experiments is shown.
(E) AND-Tg T cells from Cd28/ mice were reconstituted with WT or mutant CD28 and stimulated with PMA in combination with anti-CD28. T cell proliferation
was measured 48 hr after stimulation. The graph shows mean ± SD (n = 3) obtained by three independent experiments.Immunity 29, 589–601, October 17, 2008 ª2008 Elsevier Inc. 599
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Costimulation Regulation by TCR-CD28 Microclusterscentrifuged at 10003 g for 90min in the presence of 8 mg/ml polybrene (Sigma)
and 200 U/ml human recombinant interleukin 2 (Ajinomoto). At day 3 or later,
20%–80% of T cells were transduced on the basis of EGFP, ECFP, or EYFP
expression and sorted with FACSAria (BD) to obtain populations with
homogenous fluorescence intensity. Cells were maintained for 5–14 days in
RPMI1640medium containing 10%FCS supplemented and recombinant IL-2.
Planar and Spherical Bilayers
GPI-anchored proteins of mouse I-Ek, ICAM-1, and CD80 were transfected
into and purified from Chinese hamster ovary (CHO) or baby hamster kidney
cells and were incorporated into dioleoyl phosphatidylcholine liposomes
(DOPC, Avanti Polar Lipids). I-Ek- and ICAM-1-GPI were labeled with Cy5
mono NHS ester (Amersham Biosciences). Planar bilayers containing I-Ek-,
ICAM-1-, and CD80-GPI were generated in a flow cell chamber system
(Bioptechs). The expression levels of I-Ek, ICMA-1, and CD80 on the planar
bilayer were quantified with 5-mm-diameter silica beads (Bangs Laboratories).
Silica beadswere loadedwith DOPC containing I-Ek-, ICMA-1-, andCD80-GPI
at the same concentrations as those of the planar bilayer, stained with FITC-
labeled anti-I-Ek (14-4-4), ICMA-1 (YN1/1), or CD80 (16.10A1), and analyzed
by FACSCalibur (BD). The densities of I-Ek, ICMA-1, and CD80 on the bilayer
were calculated on the basis of standard FITC beads (Bangs Laboratories) and
adjusted to approximately 250, 100, and 60–120 molecules/mm2, respectively.
Planar bilayers were loaded with 10 mM MCC88-103 in citrate buffer, pH 4.5,
for 24 hr at 37C, blocked with 5% nonfat dried milk in PBS for 1 hr at 37C,
and left to stand in the assay medium. All planar bilayer experiments were
performed in HEPES-buffered saline containing 1% FCS, 2 mM MgCl2, and
1 mM CaCl2.
TIRF Imaging
Cells were imaged with TIRFM as previously described (Tokunaga et al., 1997).
A solid-state laser (488 nm, 20 mW; Sapphire 488-20-OPS, Coherent) and
an inverted microscope (IX-81, Olympus, Japan) were used. Images were
captured with an electron-bombarded charge-coupled device camera
(C-7190-23; Hamamatsu Photonics).
Fluorescence Imaging with Planar Bilayer
Cells transduced with various fluorescent-tagged proteins or stained by Fab
antibodies were real-time imaged by TIRFM or confocal microscopy. For
immunofluorescence staining, cells on a planar bilayer were fixed with 4%
paraformaldehyde and stained with indicated Abs in 1% BSA PBS 0.3%
saponin for 30 min at 25C after blocking with 1% BSA PBS 0.3% saponin.
All images were collected on a Leica DMIRES2 system, and data were
analyzed with Leica confocal software.
T Cell-APC Conjugation Assay
DC-1 cells were prepulsed overnight at 37C with 5 mM MCC peptide and
washed before assay. AND-TCR T cell hybridomas (2.5 3 104) expressing
ECFP-CD28 and/or EYFP-PKCqwere cultured with DC-1 on a glass-bottomed
dish for real-time imaging, or on 12 mm coverslips for fixing and staining.
T Cell Stimulation with Silica Beads
CD4+ T cells were prepared from AND-Tg mice on Rag2/ background by
magnetic cell sorting (Miltenyi Biotec). Naive or effector CD4+ T cells (5–10 3
104) were stimulated with silica beads coatedwith lipid bilayer containing I-Ek-,
ICAM-1-, and CD80-GPI prepulsed with MCC88-103 in a 96-well round-
bottomed dish. At 6 hr after stimulation, cells were stained with anti-CD69
and analyzed by FACSCalibur. At 48 hr, IL-2 in supernatants was measured
by ELISA. Also at 48 hr, the cells were pulsed with 2 Ci/well of 3H-thymidine
for 12 hr, and the incorporated radioactivity was measured with a Microbeta
scintillation counter (Amersham Pharmacia Biotech).
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